Antineoplastilised ja immunosupresseerivad ravimid
Contracts total
6 284 818 €
Bids
4
Type
Supplies
Published
30.07.2025
Tender description
Käesoleva hanke eesmärk on sõlmida raamleping antineoplastiliste ja immuunosupresseerivate ravimite ostmiseks HD Lisas 1 toodud nimetuste ja kirjelduste alusel. / Kõrvaldamise alused ja kvalifitseerimistingimused: Vaata hanke alusdokumentidest
Awarded contracts
08.12.2025| Lot | Tenderer | Amount | Bids | Awarded |
|---|---|---|---|---|
| L01AA03 Melphalan | TAMRO EESTI OÜ | 9524 € | 1 | 23.10.2025 |
| L01AX03 Temozolomid | MAGNUM MEDICAL OÜ | 14 414 € | 2 | 23.10.2025 |
| L01AX03 Temozolomid | MAGNUM MEDICAL OÜ | 10 247 € | 2 | 23.10.2025 |
| L01AB01 Busulfan | TAMRO EESTI OÜ | 35 100 € | 1 | 23.10.2025 |
| L01AC01 Thiotepa | Apteegikaubanduse Hulgimüük OÜ | 12 953 € | 2 | 27.10.2025 |
| L01AC01 Thiotepa | Apteegikaubanduse Hulgimüük OÜ | 3120 € | 1 | 27.10.2025 |
| L01BA01 Methotrexat | First Pharma OÜ | 34 736 € | 2 | 23.10.2025 |
| L01BB04 Kladribiin | MAGNUM MEDICAL OÜ | 34 043 € | 3 | 23.10.2025 |
| L01BB05 Fludarabine | OÜ Chirurgicus | 41 730 € | 3 | 23.10.2025 |
| L01BC01 Cytarabine | Apteegikaubanduse Hulgimüük OÜ | 7475 € | 2 | 27.10.2025 |
| L01BC02 Fluorouracil | OÜ Chirurgicus | 137 800 € | 2 | 23.10.2025 |
| L01BC05 Gemcitabine | Apteegikaubanduse Hulgimüük OÜ | 146 250 € | 2 | 27.10.2025 |
| L01CA01 Vinblastin | OÜ Chirurgicus | 15 600 € | 1 | 23.10.2025 |
| L01CA02 Vincristin | First Pharma OÜ | 17 160 € | 3 | 23.10.2025 |
| L01CB01 Etoposide | Apteegikaubanduse Hulgimüük OÜ | 65 000 € | 1 | 27.10.2025 |
| L01CB01 Etoposide | Apteegikaubanduse Hulgimüük OÜ | 44 366 € | 1 | 27.10.2025 |
| L01CD01 Paclitaxel | TAMRO EESTI OÜ | 41 880 € | 2 | 23.10.2025 |
| L01DB01 Doxorubicin | Apteegikaubanduse Hulgimüük OÜ | 41 600 € | 1 | 27.10.2025 |
| L01DB02 Daunorubicin | Apteegikaubanduse Hulgimüük OÜ | 16 994 € | 3 | 27.10.2025 |
| L01DB06 Idarubicin | Apteegikaubanduse Hulgimüük OÜ | 25 578 € | 4 | 27.10.2025 |
| L01DB07 Mitoxantrone | osaühing KALVERTON | 7597 € | 1 | 27.10.2025 |
| L01DC01 Bleomycin | First Pharma OÜ | 49 400 € | 1 | 23.10.2025 |
| L01DC03 Mitomycin | Apteegikaubanduse Hulgimüük OÜ | 102 362 € | 1 | 27.10.2025 |
| L01DC03 Mitomycin | Apteegikaubanduse Hulgimüük OÜ | 22 555 € | 1 | 27.10.2025 |
| L01EF01 Cetuximab | TAMRO EESTI OÜ | 16 045 € | 2 | 23.10.2025 |
| L01XA01 Cisplatin | MAGNUM MEDICAL OÜ | 87 750 € | 1 | 23.10.2025 |
| L01XA02 Carboplatin | MAGNUM MEDICAL OÜ | 82 810 € | 2 | 23.10.2025 |
| L01XA03 Oxaliplatin | MAGNUM MEDICAL OÜ | 46 332 € | 2 | 23.10.2025 |
| L01XF01 Tretionin | TAMRO EESTI OÜ | 7070 € | 4 | 23.10.2025 |
| L01XC12 Bentruximab vedotin | MAGNUM MEDICAL OÜ | 2 479 987 € | 1 | 23.10.2025 |
| L01XC80 Beetadinutuksimaab | MAGNUM MEDICAL OÜ | 518 204 € | 2 | 23.10.2025 |
| L01XX02 Asparaginase | Apteegikaubanduse Hulgimüük OÜ | 12 142 € | 3 | 27.10.2025 |
| L01EB03 Afatinib | TAMRO EESTI OÜ | 198 356 € | 2 | 23.10.2025 |
| L01EB03 Afatinib | TAMRO EESTI OÜ | 280 032 € | 2 | 23.10.2025 |
| L01CE01 Topotecan | MAGNUM MEDICAL OÜ | 70 720 € | 1 | 23.10.2025 |
| L01CE02 Irinotecan | MAGNUM MEDICAL OÜ | 27 456 € | 2 | 23.10.2025 |
| L01XG03 Ixazomib | MAGNUM MEDICAL OÜ | 10 937 € | 1 | 23.10.2025 |
| L01XG03 Ixazomib | MAGNUM MEDICAL OÜ | 54 684 € | 1 | 23.10.2025 |
| L03AX03 BCG vaccine | Apteegikaubanduse Hulgimüük OÜ | 108 427 € | 1 | 27.10.2025 |
| L04AA04 Anti-T-lymphocyte immunoglobulin | MAGNUM MEDICAL OÜ | 281 190 € | 1 | 23.10.2025 |
| L04AA06 Mükofenoolhape | Roche Eesti Osaühing | 40 040 € | 1 | 23.10.2025 |
| L04AA06 Mükofenoolhape | MAGNUM MEDICAL OÜ | 5525 € | 3 | 23.10.2025 |
| L04AA33 Vedolizumab | MAGNUM MEDICAL OÜ | 996 523 € | 1 | 23.10.2025 |
| L04AD02 Tacrolimus | TAMRO EESTI OÜ | 3315 € | 2 | 23.10.2025 |
| L04AD02 Tacrolimus | TAMRO EESTI OÜ | 19 791 € | 2 | 23.10.2025 |
Tender lots
50| Lot | Estimated value | Deadline |
|---|---|---|
| L01AA01 Cyclophosphamide | 02.09.2025 | |
| L01AA03 Melphalan | 02.09.2025 | |
| L01AA06 Ifosfamide | 02.09.2025 | |
| L01AX03 Temozolomid | 02.09.2025 | |
| L01AX03 Temozolomid | 02.09.2025 | |
| L01AB01 Busulfan | 02.09.2025 | |
| L01AC01 Thiotepa | 02.09.2025 | |
| L01AC01 Thiotepa | 02.09.2025 | |
| L01BA01 Methotrexat | 02.09.2025 | |
| L01BA01 Methotrexat | 02.09.2025 | |
| L01BB04 Kladribiin | 02.09.2025 | |
| L01BB05 Fludarabine | 02.09.2025 | |
| L01BC01 Cytarabine | 02.09.2025 | |
| L01BC02 Fluorouracil | 02.09.2025 | |
| L01BC05 Gemcitabine | 02.09.2025 | |
| L01CA01 Vinblastin | 02.09.2025 | |
| L01CA02 Vincristin | 02.09.2025 | |
| L01CB01 Etoposide | 02.09.2025 | |
| L01CB01 Etoposide | 02.09.2025 | |
| L01CD01 Paclitaxel | 02.09.2025 | |
| L01DB01 Doxorubicin | 02.09.2025 | |
| L01DB02 Daunorubicin | 02.09.2025 | |
| L01DB06 Idarubicin | 02.09.2025 | |
| L01DB07 Mitoxantrone | 02.09.2025 | |
| L01DC01 Bleomycin | 02.09.2025 | |
| L01DC03 Mitomycin | 02.09.2025 | |
| L01DC03 Mitomycin | 02.09.2025 | |
| L01EF01 Cetuximab | 02.09.2025 | |
| L01XA01 Cisplatin | 02.09.2025 | |
| L01XA02 Carboplatin | 02.09.2025 | |
| L01XA03 Oxaliplatin | 02.09.2025 | |
| L01XF01 Tretionin | 02.09.2025 | |
| L01XC12 Bentruximab vedotin | 02.09.2025 | |
| L01XC80 Beetadinutuksimaab | 02.09.2025 | |
| L01XX02 Asparaginase | 02.09.2025 | |
| L01EG01 Temsirolimus | 02.09.2025 | |
| L01EB03 Afatinib | 02.09.2025 | |
| L01EB03 Afatinib | 02.09.2025 | |
| L01CE01 Topotecan | 02.09.2025 | |
| L01CE02 Irinotecan | 02.09.2025 | |
| L01XG03 Ixazomib | 02.09.2025 | |
| L01XG03 Ixazomib | 02.09.2025 | |
| L03AX03 BCG vaccine | 02.09.2025 | |
| L03AX15 Mifamurtid | 02.09.2025 | |
| L04AA04 Anti-T-lymphocyte immunoglobulin | 02.09.2025 | |
| L04AA06 Mükofenoolhape | 02.09.2025 | |
| L04AA06 Mükofenoolhape | 02.09.2025 | |
| L04AA33 Vedolizumab | 02.09.2025 | |
| L04AD02 Tacrolimus | 02.09.2025 | |
| L04AD02 Tacrolimus | 02.09.2025 |
Similar open tenders
- Parenteraalsed toitelahusedOpen for bidsDeadline 20.10.2026 2 daysEstimated value 400 000 €Published 18.09.2026
- KlesrovimabOpen for bidsDeadline 20.10.2026 2 daysEstimated value 190 000 €Published 05.10.2026
- Puhasruumide desinfektsiooni- ja puhastusvahendidOpen for bidsDeadline 21.10.2026 3 daysPublished 17.09.2026
- Urogenitaalsüsteemi ravimid ja hormoonravimidOpen for bidsDeadline 23.10.2026 5 daysPublished 18.09.2026
- Ravim B01AB05 EnoksapariinOpen for bidsDeadline 27.10.2026 9 daysPublished 21.09.2026
- Kemoteraapias kasutatavad ravimidOpen for bidsDeadline 27.10.2026 9 daysPublished 22.09.2026
Source: Public Procurement Register open data. Amounts exclude VAT. The notice published in the Public Procurement Register is binding.